BWM
PGEN icon

Baystate Wealth Management’s Precigen PGEN Stock Holding History

Baystate Wealth Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$670 Buy
+500
New +$587 ﹤0.01% 1185
2017
Q3 		– Sell
-20
Closed -$1K – 684
2017
Q2 		$1K Hold
20
– – ﹤0.01% 610
2017
Q1 		$1K Buy
+20
New +$446 ﹤0.01% 576

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baystate Wealth Management's PGEN Position: Q4 2023 in Review

Baystate Wealth Management opened a new position in Precigen (PGEN) in Q4 2023: 500 shares worth $670. The stake represents ﹤0.01% of the portfolio and ranks #1185 among its holdings. This is a return to the name: Baystate Wealth Management previously reported a position in PGEN as recently as Q2 2017.

Baystate Wealth Management first reported a position in PGEN in Q1 2017 and has held it in 3 quarters since. The position peaked at $1K in Q2 2017. 137 funds tracked by Wall St. Rank hold PGEN as of Q4 2023.

  • Baystate Wealth Management held 500 shares of Precigen worth $670 as of Q4 2023.
  • Precigen was a new Baystate Wealth Management position in Q4 2023.
  • Precigen made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #1185 holding.
  • Baystate Wealth Management first reported a position in Precigen in Q1 2017 and has held it in 3 quarters since.
  • Baystate Wealth Management's Precigen position peaked at $1K in Q2 2017.
  • 137 funds tracked by Wall St. Rank held Precigen as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.